Cited by

• Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.

  Weisweiler P, Merk W, Jacob B, Schwandt P. Weisweiler P, et al. Eur J Clin Pharmacol. 1986;30(2):191-4. doi: 10.1007/BF00614301. Eur J Clin Pharmacol. 1986. PMID: 3709644
• Lipid profile with paternal history of coronary heart disease before age 40.

  Bistritzer T, Rosenzweig L, Barr J, Mayer S, Lahat E, Faibel H, Schlesinger Z, Aladjem M. Bistritzer T, et al. Arch Dis Child. 1995 Jul;73(1):62-5. doi: 10.1136/adc.73.1.62. Arch Dis Child. 1995. PMID: 7639553 Free PMC article.
• Hyperlipidemia and premature arteriosclerosis.

  Smith FR. Smith FR. Lipids. 1978 May;13(5):375-7. doi: 10.1007/BF02533734. Lipids. 1978. PMID: 672476
• A host of hypercholesterolaemic homozygotes in South Africa.

  Seftel HC, Baker SG, Sandler MP, Forman MB, Joffe BI, Mendelsohn D, Jenkins T, Mieny CJ. Seftel HC, et al. Br Med J. 1980 Sep 6;281(6241):633-6. doi: 10.1136/bmj.281.6241.633. Br Med J. 1980. PMID: 7437743 Free PMC article.
• The use of low density lipoprotein receptor activity of lymphocytes to determine the prevalence of familial hypercholesterolaemia in a rural South African community.

  Steyn K, Weight MJ, Dando BR, Christopher KJ, Rossouw JE. Steyn K, et al. J Med Genet. 1989 Jan;26(1):32-6. doi: 10.1136/jmg.26.1.32. J Med Genet. 1989. PMID: 2918524 Free PMC article.